about
Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma.Quantitative study of electroporation-mediated molecular uptake and cell viabilityPhysically facilitating drug-delivery systems.Optimization of skin electroporation in mice to increase tolerability of DNA vaccine delivery to patients.Non-thermal irreversible electroporation (N-TIRE) and adjuvant fractionated radiotherapeutic multimodal therapy for intracranial malignant glioma in a canine patientMR imaging to assess immediate response to irreversible electroporation for targeted ablation of liver tissues: preclinical feasibility studies in a rodent modelElectrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma.Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases.Tissue electroporation: quantification and analysis of heterogeneous transport in multicellular environmentsIntratumoral cancer chemotherapy and immunotherapy: opportunities for nonsystemic preoperative drug delivery.Comparison of flow cytometry, fluorescence microscopy and spectrofluorometry for analysis of gene electrotransfer efficiency.Effects of oscillatory electric fields on internal membranes: an analytical model.Electrochemotherapy: an emerging cancer treatment.The effect of high frequency steep pulsed electric fields on in vitro and in vivo antitumor efficiency of ovarian cancer cell line skov3 and potential use in electrochemotherapy.Locally enhanced chemotherapy by electroporation: clinical experiences and perspective of use of electrochemotherapy.Electrochemotherapy treatment of locally advanced and metastatic soft tissue sarcomas: results of a non-comparative phase II study.A model for evaluating therapeutic response of combined cancer treatment modalities: applied to treatment of subcutaneously implanted brain tumors (N32 and N29) in Fischer rats with pulsed electric fields (PEF) and 60Co-gamma radiation (RT).Diffusion-weighted MRI for verification of electroporation-based treatments.Kinetics of transmembrane transport of small molecules into electropermeabilized cells.Cell responses without receptors and ligands, using nanosecond pulsed electric fields (nsPEFs)Natural fluctuations of an electropore show fractional Lévy stable motion.Theoretical evaluation of voltage inducement on internal membranes of biological cells exposed to electric fields.Effect of electrically mediated intratumor and intramuscular delivery of a plasmid encoding IFN alpha on visible B16 mouse melanomas.Electrically mediated plasmid DNA delivery to hepatocellular carcinomas in vivo.Prediction and optimization of gene transfection and drug delivery by electroporation.Cancer cells ablation with irreversible electroporation.Electrically mediated delivery of vector plasmid DNA elicits an antitumor effect.Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation.A new theoretical model for transmembrane potential and ion currents induced in a spherical cell under low frequency electromagnetic field.Variability of the minimal transmembrane voltage resulting in detectable membrane electroporation.Electroporation-enhanced transdermal diclofenac sodium delivery into the knee joint in a rat model of acute arthritis.
P2860
Q24651349-F25AE657-3048-4CBE-B11C-00627DC2BBB0Q28346285-D09455B1-F2D0-4CED-AAA8-B88046F2EB02Q30462003-7900EBA4-B872-42C2-9166-387623D73462Q33714027-2077FFB1-66B5-4A86-92DC-4814F7742569Q33788237-5AA515B2-F27F-444A-AE8D-EE15C46F42B7Q34017733-0504A556-000B-42E9-B4D9-AE859D5D8BB4Q34020065-D1BF4264-8041-4C9A-B820-C24541D88189Q34022431-99E74ECF-B73A-4716-9BC2-24204E38B606Q34185762-AF2634BC-F802-407B-BEF2-370327D70F60Q34534003-FB842E06-B64B-48A7-AB80-0C587C713DB2Q35229556-B510753F-66D5-4B2A-BEDE-99C6449BF466Q36481406-3782C1DD-A7AE-43F9-9372-F0245A2E288AQ37130253-2218236A-3692-4F67-ADED-BBFC7E8FC767Q37202948-527B7DAF-4242-4574-9C6E-AFCE07C1C2A6Q38209607-B7DFB9BB-6407-4CE5-B79C-8E4453885C6FQ39324450-92244D3D-565D-423F-A052-0520E347F55DQ40628794-C65402C8-2959-4F8C-9E69-734FCC3E8E02Q42056564-BDDA650F-FF98-408A-9399-4E914C46F119Q42423765-C3101344-E2B2-469D-A398-AAD80DBEC2ABQ42608489-0F20DB6A-A051-48A6-81EE-4A54BF3FAA58Q42806814-9AE54A49-45CC-4458-853B-CDDFAC9F7BE1Q43203388-78F9A259-F16A-4CF4-BD8D-3BF5BE0E9C5DQ45859152-A7695A83-12E4-4536-B111-5F220FA359DDQ45868394-A1F3AA21-1B65-4F94-A08C-85D38AA55B0EQ45880352-9DA7A2EB-9955-47E1-95AA-D67D24BD9C41Q45888645-7D02A434-FDE3-4ADB-ADB6-8D1858E5065CQ45889308-4EA12A8C-BBFA-4F27-867B-449C965B8523Q46394443-4D21869E-219D-4F81-A4C9-EA4D3A1963F9Q50607132-8D9F5CC8-C3B4-4F71-9A5A-56057D9B136EQ51784035-1C62014D-5E93-4D27-84F8-632015EB290FQ55440729-A7EEA8B1-E756-4ABD-B16B-0D121023715B
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Clinical applications of electrochemotherapy.
@ast
Clinical applications of electrochemotherapy.
@en
type
label
Clinical applications of electrochemotherapy.
@ast
Clinical applications of electrochemotherapy.
@en
prefLabel
Clinical applications of electrochemotherapy.
@ast
Clinical applications of electrochemotherapy.
@en
P2093
P1476
Clinical applications of electrochemotherapy.
@en
P2093
Jaroszeski MJ
P304
P356
10.1016/S0169-409X(98)00067-2
P407
P577
1999-01-01T00:00:00Z